Allison Aubrey
Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.
Along with her NPR science desk colleagues, Aubrey is the winner of a 2019 Gracie Award. She is the recipient of a 2018 James Beard broadcast award for her coverage of 'Food As Medicine.' Aubrey is also a 2016 winner of a James Beard Award in the category of "Best TV Segment" for a PBS/NPR collaboration. The series of stories included an investigation of the link between pesticides and the decline of bees and other pollinators, and a two-part series on food waste. In 2013, Aubrey won a Gracie Award with her colleagues on The Salt, NPR's food vertical. They also won a 2012 James Beard Award for best food blog. In 2009, Aubrey was awarded the American Society for Nutrition's Media Award for her reporting on food and nutrition. She was honored with the 2006 National Press Club Award for Consumer Journalism in radio and earned a 2005 Medical Evidence Fellowship by the Massachusetts Institute of Technology and the Knight Foundation. In 2009-2010, she was a Kaiser Media Fellow.
Joining NPR in 2003 as a general assignment reporter, Aubrey spent five years covering environmental policy, as well as contributing to coverage of Washington, D.C., for NPR's National Desk. She also hosted NPR's Tiny Desk Kitchen video series.
Before coming to NPR, Aubrey was a reporter for the PBS NewsHour and a producer for C-SPAN's Presidential election coverage.
Aubrey received her Bachelor of Arts degree from Denison University in Granville, Ohio, and a Master of Arts degree from Georgetown University in Washington, D.C.
-
Coronavirus cases are surging around the country. How will Joe Biden manage the pandemic differently, once he takes office in January? Expect a more centralized U.S. response plan, his team says. -
With cases surging, the coronavirus pandemic is heating up as an election issue. Voters have seen President Trump's approach to the crisis play out in real-time, but how would Biden handle things? -
Pediatricians have been asking policy makers to include children in COVID-19 vaccine trials. Now, the FDA has given Pfizer approval to enroll adolescents as young as 12 years old. -
Trump has already received an infusion of Regeneron's experimental antibody cocktail. Here's a look at other treatments and tests he's likely to get as doctors monitor his condition in coming days. -
Scientists are racing to develop a vaccine that proves "safe and effective." It may not prevent infection in everyone who gets it, but it still could eventually stop the pandemic. Here's how. -
Some colleges are betting on new, proprietary tests they've developed to keep the college safe. The idea is, test everyone at least twice a week and you can catch most infections early. -
As schools weigh the risks of reopening, many are making plans to lower the risks of coronavirus transmission. Here's how to vet your school's proposals. -
Studies show children have lower rates of COVID-19 and have milder symptoms than adults. But there's less information on how much kids spread the coronavirus, which is key to safely reopen schools. -
The U.S. has had about 10 times more coronavirus cases than were captured by testing, according to new estimates released by the federal government. -
If you miss your mom and dad — or they miss their grandkids — how safe is a summer trip? Older people are more likely to get seriously ill from the coronavirus, so consider these tips to reduce risk.
